Pfizer to temporary US well being officers on coronavirus booster shot: report
Pfizer is expected to notify US health officials of the need for a COVID-19 booster vaccination in the coming days, multiple sources told the Washington Post.
The news of the reported briefing comes after government agencies this week rejected the vaccine maker’s announcement that it is seeking approval for a third dose of its coronavirus vaccination.
Pfizer and six people familiar with the plans confirmed to the newspaper that a meeting could likely take place on Monday. The meeting is expected to resemble a briefing the company gave to European officials last week about a possible booster vaccination.
Those familiar with the matter, who spoke to the Post on condition of anonymity, said those invited to the scheduled briefing included the Chief Medical Officer of the White House Anthony FauciAnthony FauciFauci Says Pfizer Boss Apologized for Not Giving Up Booster Announcement Pfizer Seeks FDA Approval for COVID-19 Vaccine Boost | House report: Pharmaceutical companies spent MORE on buybacks and dividends than on research, Director of the National Institutes of Health (NIH) Francis Collins and Director of the Centers for Disease Control and Prevention (CDC) Rochelle WalenskyRochelle WalenskyThe Hill’s Morning Report: Afghanistan’s Future Now Rests With Afghans, Biden Says California Capitol Tightening Mask Policy Following Recent COVID-19 Cases Risks Rise As The Vaccine Picks With Trump Counties Widen MORE.
Janet Woodcock, Acting Commissioner of the Food and Drug Administration (FDA), Chief COVID-19 Science Officer David Kessler and the Surgeon General, Vivek MurthyVivek MurthyWhite House Sends Top Officials For Vaccine Blitz White House Admits Vaccine Marker Will Be Missed On July 4th The Hill’s Morning Report – After High-profile Biden-Putin Summit, What Now? MOREThey were also invited, according to the post.
A Pfizer spokesman confirmed the meeting to the Post, but the representative made no further information.
The Hill has approached Pfizer for comment, as well as the White House, CDC, and Department of Health (HHS).
The question of whether a COVID-19 booster vaccination is needed in the future sparked a debate this week after Pfizer / BioNTech said the companies had seen it “Encouraging data” from an ongoing trial of a third vaccination.
The companies also cited data from the Israel Ministry of Health showing that “the vaccine’s effectiveness in preventing infections and symptomatic illnesses decreased six months after vaccination.”
However, US health officials quickly pushed back, and the CDC and FDA said in a joint statement shortly after Pfizer’s announcement that “Americans who have been fully vaccinated will not need a booster at this point.”
“The FDA, CDC and NIH are running a science-based, rigorous process to see if or when a refresher might be needed,” the statement said. “This process takes into account laboratory data, clinical trial data, and cohort data – which may include data from certain pharmaceutical companies, but cannot rely solely on that data.”
“We will continue to review all new data as it becomes available and will keep the public informed,” the agencies said. “We are prepared for booster doses when science shows they are needed.”
Some experts have warned that drug companies have a financial incentive to develop more vaccines for their vaccines and that the government is buying more doses.
Fauci said Friday that Pfizer CEO Albert Bourla called him to apologize for failing to warn senior health officials prior to the company’s announcement that it would seek FDA approval for a third dose.
The nation’s leading infectious disease expert said the “coordinated coordination” between pharmaceutical companies and government agencies “has been extremely good in introducing vaccines over the past four or five months.”